ABPI publishes industry payments to health professionals and organizations

30 June 2016
abpi-big-1

Trade group the Association of the British Pharmaceutical Industry (ABPI) has today published for the first time details of payments or benefits in kind - made to doctors, nurses and pharmacists, as well as other health professionals and healthcare organizations in the UK on a publicly accessible database - Disclosure UK ( www.disclosureuk.org.uk).

This new database, available to download on the ABPI website ( www.disclosureuk.org.uk), shows payments from 109 pharmaceutical companies in the UK (54 ABPI member companies and 55 non-member companies).

The data shows that in 2015, industry spent a total of £340.3 million ($456.0 million) on working with health professionals and organizations, of which £229.3 million (67%) is for activities related to the research and development of new medicines.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical